Lilly licenses Hanmi's sonefpeglutide (LAPSGLP-2 analog) for multiple indications SEOUL, South Korea, June 1, 2026 /PRNewswire/ -- Hanmi Pharm. Co., Ltd. ("Hanmi") today announced that they have entered into a license agreement for the development, manufacturing and commercialization of...
Hence then, the article about hanmi signs licensing deal with lilly for sonefpeglutide lapsglp 2 analog was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Hanmi Signs Licensing Deal with Lilly for sonefpeglutide (LAPSGLP-2 analog) )
Also on site :
- Berkshire Hathaway to Acquire Taylor Morrison Home Corporation for $8.5 Billion
- Why does Erdogan want a new constitution?
- When Does the ‘Euphoria’ Season 3 Finale Come Out? How and When to Watch